DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,785,050 | +11.8% | 135,000 | +59.9% | 0.00% | 0.0% |
| Q2 2023 | $2,491,293 | +22.4% | 84,422 | -4.4% | 0.00% | +50.0% |
| Q1 2023 | $2,034,939 | -26.2% | 88,322 | -11.0% | 0.00% | -33.3% |
| Q4 2022 | $2,759,002 | +0.1% | 99,209 | +5.4% | 0.00% | 0.0% |
| Q3 2022 | $2,757,000 | -22.7% | 94,123 | -22.4% | 0.00% | -25.0% |
| Q2 2022 | $3,568,000 | -16.6% | 121,223 | -8.9% | 0.00% | 0.0% |
| Q1 2022 | $4,280,000 | -21.6% | 133,037 | +8.7% | 0.00% | -20.0% |
| Q4 2021 | $5,456,000 | -14.7% | 122,337 | -3.5% | 0.01% | -28.6% |
| Q3 2021 | $6,399,000 | -1.1% | 126,837 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $6,472,000 | -19.5% | 126,837 | -9.9% | 0.01% | -22.2% |
| Q1 2021 | $8,042,000 | -28.3% | 140,837 | +5.2% | 0.01% | -35.7% |
| Q4 2020 | $11,209,000 | +216.2% | 133,824 | +35.3% | 0.01% | +180.0% |
| Q3 2020 | $3,545,000 | +154.5% | 98,944 | +71.8% | 0.01% | +150.0% |
| Q2 2020 | $1,393,000 | +143.1% | 57,607 | +76.1% | 0.00% | +100.0% |
| Q1 2020 | $573,000 | +37.1% | 32,707 | +36.3% | 0.00% | 0.0% |
| Q4 2019 | $418,000 | +13.6% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $368,000 | -27.7% | 24,000 | -2.0% | 0.00% | 0.0% |
| Q2 2019 | $509,000 | -6.3% | 24,500 | +4.7% | 0.00% | 0.0% |
| Q1 2019 | $543,000 | +14.8% | 23,400 | +2.2% | 0.00% | 0.0% |
| Q4 2018 | $473,000 | -2.9% | 22,900 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $487,000 | +94.8% | 22,400 | +36.6% | 0.00% | – |
| Q2 2018 | $250,000 | -22.6% | 16,400 | 0.0% | 0.00% | – |
| Q1 2018 | $323,000 | – | 16,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |